5439 results for "Psychedelics"
Serotonergic Psychedelics LSD & Psilocybin Increase the Fractal Dimension of Cortical Brain Activity in Spatial and Temporal Domains
OpenAlex – January 11, 2019
Summary
Brain activity becomes more 'fractal' under psychedelics like psilocybin, profoundly altering consciousness. Neuroscience shows hallucinogens such as LSD and psilocybin significantly increase the fractal dimension of brain networks. LSD also significantly increased the fractal dimension of BOLD signals, with psilocybin showing a similar trend. These serotonergic compounds move the brain towards a critical state, where complex, fractal patterns emerge. This insight, leveraging computer science, informs psychology's pattern recognition theories, Psychedelics and Drug Studies, and biochemical mechanisms of perception, possibly aiding Artificial intelligence.
Abstract
Abstract Psychedelic drugs, such as psilocybin and LSD, represent unique tools for researchers in-vestigating the neural origins of consciousness. ...
Beyond the psychedelic hype: Exploring the persistence of the neoliberal paradigm
Journal of Psychedelic Studies – September 21, 2023
Summary
The burgeoning psychedelics industry, despite promises for mental health, risks perpetuating the very issues it claims to solve. It aligns with neoliberal ideology, promoting medicalization and commodification of mental distress, a key finding in sociology and political economy. Instead of challenging the psychopharmaceutical status quo, it individualizes suffering through depoliticisation and pathologisation, distracting from systemic roots in politics and precarity. To truly address mental illness and foster well-being amidst challenges like ecological collapse, psychedelics must decouple from profit-driven incentives.
Abstract
Abstract Background and Aims Advocates of psychedelic medicine have positioned psychedelics as a novel therapeutic intervention that will solve the...
Systematic review and rationale of using psychedelics in the treatment of cannabis use disorder.
Frontiers in psychiatry – January 01, 2023
Summary
Psychedelics may offer new hope for treating cannabis use disorder, which affects millions of Americans. Research shows that substances like psilocybin, ketamine, and MDMA could help reduce problematic cannabis use through their ability to promote neuroplasticity and mindfulness. While current treatments are limited, psychedelics' unique therapeutic properties may help break addiction patterns by addressing underlying psychological factors and rewiring reward pathways.
Abstract
Cannabis use disorder (CUD) is prevalent in ~2-5% of adults in the United States and is anticipated to increase as restrictions to cannabis decreas...
Are we hallucinating or can psychedelic drugs modulate the immune system to control inflammation?
British journal of pharmacology – July 28, 2025
Summary
Psychedelic drugs, known for activating the 5-HT2A receptor, are revealing a surprising ability to modulate the immune system. Evidence suggests they effectively reduce inflammation, including neuroinflammation, by inhibiting pro-inflammatory responses. Animal and early human data support these positive effects. Crucially, new compounds are being developed that offer these anti-inflammatory benefits without the psychedelic experience, presenting innovative avenues for treatment.
Abstract
Psychedelic drugs that activate 5-HT2A receptors have been long used for cultural, medicinal and recreational purposes. Interest in psychedelics fo...
Psychological flexibility mediates the relations between acute psychedelic effects and subjective decreases in depression and anxiety.
Journal of contextual behavioral science – January 01, 2020
Summary
A fascinating insight reveals that the therapeutic benefits often reported after using psychedelics may stem from a specific psychological shift. This research explored whether increased psychological flexibility acts as the crucial mechanism linking acute hallucinogen experiences to improved mental well-being. A survey of nearly 1,000 individuals found that profound mystical and insightful experiences during psychedelic use were strongly associated with subsequent reductions in anxiety and depression. Crucially, statistical analysis confirmed this positive impact was fully explained by an observed increase in psychological flexibility. This suggests that psychedelics foster an adaptive mental state, serving as the key to alleviating symptoms of anxiety and depression.
Abstract
Prior research has shown that acute subjective psychedelic effects are associated with both spontaneous and intended changes in depression and anxi...
Ethical Issues Regarding Nonsubjective Psychedelics as Standard of Care.
Cambridge quarterly of healthcare ethics : CQ : the international journal of healthcare ethics committees – October 01, 2022
Summary
The profound subjective experiences induced by psychedelics are key to their healing potential. With new hallucinogens emerging that aim to treat mental health conditions in psychiatry without these "trips," bioethics asks a crucial question: Is it ethical to withhold these typically positive, meaningful experiences? While nonsubjective psychedelics have a role for specific cases, the full, transformative subjective journey should be the default standard of care due to its significant therapeutic benefits.
Abstract
Evidence suggests that psychedelics bring about their therapeutic outcomes in part through the subjective or qualitative effects they engender and ...
Psychedelics: Alternative and Potential Therapeutic Options for Treating Mood and Anxiety Disorders
Molecules – April 13, 2022
Summary
For thousands of years, psychedelics like psilocybin and lysergic acid diethylamide held spiritual and medicinal value in ancient cultures. Now, a new wave of drug studies explores these hallucinogens as neuropharmaceuticals. Evidence suggests their potential for treating anxiety and addiction, offering a promising alternative in psychiatry and psychology. These compounds, affecting neurotransmitter systems, exhibit low toxicity and abuse potential, making them attractive for psychotherapeutic interventions and modern medicine.
Abstract
The word “psychedelic” (psyche (i.e., the mind or soul) and delos (i.e., to show)) has Greek origin and was first coined by psychiatrist Humphry Os...
Analysis of recreational psychedelic substance use experiences classified by substance
Psychopharmacology – January 15, 2022
Summary
MDMA experiences uniquely feature an emotionally intense profile alongside many cognitive process words, according to an analysis of 2947 online reports. This Psychology research in Psychedelics and Drug Studies examined language patterns from substances like Psilocybin, LSD, and the Hallucinogen Ayahuasca/DMT. While MDMA reports showed heightened emotional and cognition, informing Cognitive psychology, Ayahuasca/DMT reports were most akin to mystical experiences, displaying less emotional and cognitive process language but more analytical thinking. These distinct linguistic profiles offer insights for Clinical psychology treatments and understanding Neurotransmitter Receptor Influence on Behavior.
Abstract
Abstract Rationale and objectives Differences among psychedelic substances regarding their subjective experiences are clinically and scientifically...
Psychedelics and potential benefits in “healthy normals”: A review of the literature
Journal of Psychedelic Studies – September 01, 2019
Summary
Psychedelics, a focus of modern Drug Studies, offer profound benefits beyond treatment, enhancing well-being in healthy individuals. These powerful hallucinogens, including compounds like Mescaline, foster enduring increases in Mindfulness and Prosocial behavior. Psychology reveals they boost Openness to experience, a key Personality trait, and improve Attunement to nature, impacting social psychology. Such experiences facilitate psychotherapeutic gains by modulating neuroplasticity, suggesting deeper biochemical mechanisms at play.
Abstract
We are in the midst of a psychedelic research renaissance. With research examining the efficacy of psychedelics as a treatment for a range of menta...
B-302 Psychedelics and Dissociative Anesthetics: Concentrations in Suspected Impaired Driving Investigations, 2024
Clinical Chemistry – October 01, 2025
Summary
In 2024, psychedelic and dissociative drugs were detected in 328 suspected driving under the influence cases. Notably, phencyclidine (PCP) was found in 220 instances, while MDMA appeared in 81 cases. Ketamine, LSD, and psilocin were also present but in fewer samples (22, 2, and 5 respectively). Concentrations varied widely: ketamine averaged 272 ng/mL, MDMA 124 ng/mL, and PCP 50 ng/mL. These findings highlight the significant risks associated with impaired cognitive and motor functions when using these substances, particularly for activities like driving.
Abstract
Abstract Background Psychedelic and dissociative drugs, including psilocybin, lysergic acid diethylamide (LSD), 3,4-methylenedioxymethamphetamine (...
Minorities' Diminished Psychedelic Returns: Income and Educations Impact on Whites, Blacks, Hispanics, and Asians.
Journal of racial and ethnic health disparities – June 01, 2025
Summary
Income and education levels significantly influence how different racial groups respond to psychedelics for mental health benefits. While white individuals show reduced psychological distress with psychedelic use, minorities experience diminished returns - even at higher socioeconomic levels. Notably, educated, high-income Asian users reported increased distress, highlighting how ethnicity and inequality shape therapeutic outcomes.
Abstract
Growing evidence suggests that the race and ethnic minority population may experience fewer protective effects of psychedelics on mental health. Th...
Longitudinal associations between psychedelic use and unusual visual experiences in the United States and the United Kingdom.
Journal of psychopharmacology (Oxford, England) – January 01, 2024
Summary
First-time users of psychedelics like LSD and psilocybin are more likely to experience lasting visual effects after their initial experience. A large study tracking 7,667 adults in the US and UK found that people who used psychedelics reported increased unusual visual phenomena afterward, with newcomers showing the strongest effects. These changes suggest potential risks but were generally mild.
Abstract
Whereas findings from case reports and cross-sectional studies suggest that naturalistic psychedelic use may be associated with unusual visual expe...
Mixed-Methods Study of Use and Attitudes About Psychedelics for Therapeutic Purposes Among Low-Income U.S. Veterans Nationally.
Journal of psychoactive drugs – March 24, 2025
Summary
Only 5.6% of low-income U.S. veterans have used psychedelics for therapeutic purposes, yet 23.2% support their legalization for mental health treatment. In a survey of 1,031 veterans, those with behavioral health issues and psychosocial problems were more likely to use psychedelics therapeutically. While many expressed positive views based on personal experiences, concerns about risks and effectiveness also emerged. This highlights the potential for psychedelics to address mental health challenges in this population, alongside a growing interest in legalizing these substances for therapeutic use.
Abstract
There is great public and clinical interest in the use of psychedelics for therapeutic purposes. However, there has been little national study of p...
Acute subjective effects of psychedelics in naturalistic group settings prospectively predict longitudinal improvements in trauma symptoms, trait shame, and connectedness among adults with childhood maltreatment histories.
Progress in neuro-psychopharmacology & biological psychiatry – April 02, 2025
Summary
Participants with childhood maltreatment histories experienced significant psychological benefits from psychedelics, with improvements in PTSD symptoms and shame observed in 85 adults. Over two months, PTSD symptoms decreased by 73% to 112%, while feelings of social connectedness rose substantially. The acute effects of the psychedelic experience correlated strongly with these lasting changes. Engaging in organized ceremonies or raves appears to create supportive environments that enhance therapeutic outcomes, suggesting a promising avenue for addressing trauma-related challenges through psychedelics.
Abstract
Studies of psychedelic use in naturalistic and clinical settings have suggested safety and mental health benefits for adults with histories of chil...
From Egoism to Ecoism: Psychedelics Increase Nature Relatedness in a State-Mediated and Context-Dependent Manner.
International journal of environmental research and public health – December 16, 2019
Summary
Psychedelic use can significantly enhance nature relatedness, with lasting effects observed up to two years post-experience. In a study involving 654 participants, those who used psychedelics reported increased nature relatedness two weeks (20% increase), four weeks (25% increase), and two years (30% increase) later. This boost in connection to nature correlated with improved psychological well-being, particularly when participants experienced ego-dissolution and felt influenced by their natural surroundings during the acute effects of psychedelics. Such findings highlight potential benefits for mental health and ecological awareness.
Abstract
(1) Background: There appears to be a growing disconnection between humans and their natural environments which has been linked to poor mental heal...
Impact of a Naturalistic Psychedelic Experience on Smoking: A Retrospective Survey.
Journal of psychoactive drugs – January 01, 2023
Summary
A psychedelic experience can significantly reduce tobacco addiction. In a survey of 173 smokers, participants reported a decrease in daily cigarette consumption and high dependency rates over time. Those who successfully reduced or quit smoking experienced more intense mystical moments during their psychedelic sessions and had lower psychological flexibility beforehand. Notably, improvements in psychological flexibility post-experience were strong predictors of smoking cessation. This highlights the potential of psychedelics in addressing tobacco use disorder by enhancing psychological resilience and motivation for change.
Abstract
Tobacco use disorder is a major public health concern. The aim of this study was to investigate the impact of a psychedelic experience in a natural...
Psychedelics and Psychotherapy.
Pharmacopsychiatry – July 01, 2021
Summary
Psychedelics may enhance psychotherapy by amplifying therapeutic processes, according to a review of their effects. With insights from various clinical trials involving hundreds of participants, the analysis highlights that psychedelics share features with effective psychotherapies, such as improving meaning and relationships. Importantly, they also introduce unique elements that can benefit diverse therapeutic approaches. By establishing a framework that combines these aspects, the findings aim to enrich understanding of how psychedelics can be integrated into clinical practices while addressing ethical considerations in therapy design.
Abstract
Psychedelics have shown great promise in modern clinical trials for treating various psychiatric conditions. As a transdiagnostic treatment that ex...
A Systematic Review and Meta-Analysis Investigating the Efficacy of Various Psychedelic Drugs for the Treatment of Substance Use Disorder.
Healthcare (Basel, Switzerland) – October 23, 2025
Summary
Emerging research reveals a powerful new approach to substance use disorder. A comprehensive analysis of human trials shows that psychedelic treatment, utilizing compounds like ibogaine and psilocybin, effectively reduces substance misuse. Ibogaine, in particular, demonstrated the most prominent positive results. These significant benefits were observed whether or not the psychedelic treatment was paired with psychotherapy, highlighting the direct impact of these compounds in addressing substance use disorder.
Abstract
Objectives: This study investigates psychedelic drugs to treat substance use disorder (SUD). Researchers have recently begun conducting clinical tr...
0391 Racial/Ethnic Differences in Psychedelic Use and Sleep Satisfaction: Preliminary Findings from the Herbal Heart Study
SLEEP – May 01, 2025
Summary
A surprising finding in psychology highlights a complex link between psychedelic use and sleep satisfaction. Among 200 young adults, particularly within the Hispanic/Latino ethnic group, consuming psychedelics was associated with significantly poorer sleep. For instance, 33.9% of Hispanic/Latino psychedelic users reported sleep dissatisfaction, compared to 17.2% of non-users. Psilocybin users in this group faced 9.2 times higher odds of dissatisfaction. This insight from drug studies informs future medicine, clinical psychology, and psychiatry, emphasizing tailored support for sleep health.
Abstract
Abstract Introduction Research on psychedelic use and sleep satisfaction remains unclear despite increased use. This study examines the psychedelic...
Knowledge, perceptions, and use of psychedelics for mental health among autistic adults: An online survey
PLOS mental health. – December 26, 2025
Summary
Autistic adults show strong interest in psychedelics for mental health support. A computer-assisted web interviewing survey of 261 autistic participants found 77.8% willing to try psychedelics like psilocybin for conditions such as anxiety, often addressed in clinical psychology. Remarkably, 69.7% reported past use, with higher doses correlating with lasting mental health improvements. Descriptive statistics underscore the need for inclusive psychiatry and mental health services, acknowledging autistic individuals' distinct needs compared to neurotypical populations in psychedelics and drug studies.
Abstract
Psychedelics such as psilocybin, LSD, and MDMA have shown promise in treating mental health conditions (e.g., depression, post-traumatic stress dis...
Longitudinal associations between psychedelic use and meditation practices in the United States and the United Kingdom.
Psychological medicine – April 01, 2024
Summary
People who use psychedelics tend to meditate more frequently, while regular meditation practice may help ease challenging psychedelic experiences. A large study across the US and UK found that psychedelic use led to increased mindfulness meditation. Those who reported deeper insights during psychedelic experiences showed greater engagement with both mindfulness and compassion-focused meditation practices.
Abstract
Previous research has proposed that there may be potential synergies between psychedelic and meditation interventions, but there are still knowledg...
A protocol for a scoping review of variations among psychedelic interventions for psychological suffering associated with the end-of-life.
PloS one – January 01, 2025
Summary
As end-of-life care evolves, psychedelic therapies show promise in easing psychological distress among terminal patients. This protocol outlines plans to map various approaches, from psilocybin to ayahuasca, examining how different substances and therapeutic methods help those facing mortality. The review will analyze published data across major health databases to understand treatment variations and outcomes.
Abstract
Psychedelic substances are increasingly recognized for their therapeutic potential to ease psychological suffering linked to end-of-life issues. Ho...
The Afterglow Inventory (AGI): Validation of a new instrument for measuring subacute effects of classic serotonergic psychedelics
Journal of Psychopharmacology – March 31, 2025
Summary
The positive psychological "Afterglow" from hallucinogens like psilocybin or lysergic acid diethylamide is now quantifiable. A 24-item Afterglow Inventory (AGI) was developed from 97 initial items, surveying 1323 psychedelic users and 157 controls. The AGI effectively distinguishes groups, crucial for clinical psychology and Psychedelics and Drug Studies. AGI scores correlated with acute effect intensity (r=0.165) and positive valence (r=0.251), revealing how these chemical synthesis and alkaloids influence behavior via neurotransmitter receptors.
Abstract
Background: Classic psychedelics such as psilocybin and lysergic acid diethylamide are anecdotally associated with the phenomenon of “psychedelic a...
Present and future of metabolic and metabolomics studies focused on classical psychedelics in humans.
Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie – December 31, 2023
Summary
Groundbreaking research reveals how psychedelics like psilocybin, LSD, and ayahuasca affect human biology at the molecular level. Scientists tracked how these compounds are processed in the body and mapped their effects on cellular metabolism. While we understand how these substances break down, their broader impact on the body's metabolic systems offers promising insights for mental health treatments.
Abstract
Psychedelics are classical hallucinogen drugs that induce a marked altered state of consciousness. In recent years, there has been renewed attentio...
Measuring psychotherapeutic processes in the context of psychedelic experiences: Validation of the General Change Mechanisms Questionnaire (GCMQ)
Journal of Psychopharmacology – May 01, 2024
Summary
A new psychology tool reveals how psychedelic experiences activate mechanisms akin to psychotherapy. Validated with 1153 English-speaking and 714 German-speaking users, this instrument measures five "change mechanisms" like resource activation and mastery. Critically, these processes moderated the link between stressful life events and well-being. This cross-cultural analysis provides a crucial framework for clinical psychology and drug studies, helping psychotherapists understand how diverse contexts influence psychedelic effects, potentially informing safer use and therapeutic applications.
Abstract
Background: Therapeutic and salutogenic effects of psychedelic drugs have been attributed to psychotherapeutic or psychotherapy-like processes that...
Present and future of metabolic and metabolomics studies focused on classical psychedelics in humans
Biomedicine & Pharmacotherapy – December 31, 2023
Summary
Understanding how the body processes psychedelic compounds is vital for unlocking their therapeutic potential. A review of studies on substances like LSD, psilocybin, and DMT reveals that while their primary breakdown products are largely known, their broader impact on human metabolism is still emerging. Integrating advanced metabolomics with drug tracking promises to illuminate the precise molecular interactions behind their positive therapeutic effects, paving the way for novel treatment development.
Abstract
Psychedelics are classical hallucinogen drugs that induce a marked altered state of consciousness. In recent years, there has been renewed attentio...
Historicizing psychedelics: counterculture, renaissance, and the neoliberal matrix
Frontiers in Sociology – September 21, 2023
Summary
The "psychedelic renaissance" has paradoxically defused their radical potential. Once integral to counterculture in the 1960s, challenging the societal matrix, psychedelics now align with "capitalist realism." Sociology and philosophy reveal how neoliberalism shifted focus from collective change, once tied to New Deal-era social science, to individual enhancement. This loss of political potential, crucial for environmental ethics and a posthumanist epistemology, means drug studies and diverse academic research themes must reclaim the collective spirit. Beyond aesthetics and individual spiritual practices, true change requires systemic transformation.
Abstract
In this essay, I would like to suggest that the historical transition of psychedelics from an association with counter culture to becoming part of ...
Serotonin, psychedelics and psychiatry
World Psychiatry – September 07, 2018
Summary
In Psychiatry, just one or two psychedelic treatment sessions can yield therapeutic effects lasting several months for mood disorders and addiction—an unprecedented outcome. Neuropsychopharmacology reveals Serotonin's complex role, with 5-HT2A neurotransmitter receptor influence on behavior being key to the "psychedelic experience" and heightened context sensitivity. This shift in Medicine and Drug Studies, moving beyond traditional psychoanalysis and simple Serotonin deficiency models, highlights new Psychology avenues exploring how these compounds, often alkaloids, profoundly impact mental health.
Abstract
Serotonin is a key neuromodulator known to be involved in brain development, perception, cognition, and mood. However, unlike as with dopamine for ...
Counselors’ attitudes toward psychedelics and their use in therapy
Journal of Counseling & Development – March 19, 2022
Summary
The "psychedelic renaissance" heralds a new era in mental healthcare, with MDMA and psilocybin nearing FDA approval for therapeutic use. This profound shift is reshaping Psychiatry and Clinical Psychology, yet the counseling profession has been slow to engage. A recent poll of psychotherapists revealed mixed attitudes toward hallucinogen use, though support was strong for medically supervised applications. Crucially, most counselors recognized the immense potential of these Psychedelics in therapy, underscoring a burgeoning interest within Psychology and the broader realm of Drug Studies.
Abstract
Abstract The ‘‘psychedelic renaissance’’ is generating new evidence for psychedelics’ potential to treat numerous mental and substance use disorder...
Advances in Psychedelic Medicine
OpenAlex – January 01, 2019
Summary
Psychedelics are rapidly transforming Medicine, with the U.S. government lifting its testing ban over a decade ago. Substances like Psilocybin, MDMA, and the hallucinogen Ayahuasca are now being integrated into Psychiatry and Psychology, augmenting psychotherapies for conditions like Addiction and depressive disorders. This comprehensive assessment covers clinical efficacy, safety, and ethical considerations, alongside neuroscience findings. It also explores microdosing, cannabinoid research, and training future psychotherapists in this evolving field of Psychedelics and Drug Studies.
Abstract
Researchers, program administrators, and practicing clinicians explain the most recent developments in using psychedelic substances to treat psycho...
How psychedelics legalization debates could differ from cannabis
Addiction – August 13, 2024
Summary
Compellingly, infrequent users account for 60% of psychedelic use days monthly, versus only 5% for cannabis, highlighting distinct patterns. Over two dozen jurisdictions deprioritized enforcement of psychedelics possession. Oregon and Colorado's legislature legalized psilocybin; Colorado also approved 'grow and give' for mescaline and other hallucinogens. Despite parallels with Cannabis, political science and criminology observe differing market dynamics and unique psychological effects, sometimes interpreted as paranormal. Lawmakers must consider these nuances, informed by drug studies and cannabis and cannabinoid research, to avoid past federal inaction.
Abstract
An increasing number of US states and localities are implementing or considering alternatives to prohibiting the supply and possession of some psyc...
Mind the gap! Addressing unresolved aspects of abuse potential evaluation and scheduling of classic and novel psychedelic drugs
Journal of Psychopharmacology – October 16, 2025
Summary
The rapid advancement in Psychedelics and Drug Studies presents significant regulatory hurdles for new drug candidates. Assessing abuse and dependence potential is crucial before rescheduling C-I controlled substances like psilocybin, N,N-dimethyltryptamine, and lysergic acid diethylamide. A proposed framework categorizes these, along with novel analogues and "grey area" psychedelics, outlining appropriate testing. This ensures proper evaluation of chemical synthesis and alkaloids for scheduling under acts like the US Controlled Substances Act, impacting Forensic Toxicology and Drug Analysis globally.
Abstract
Psychedelic research is progressing at breakneck speed and is creating new challenges for drug developers, regulatory authorities, and legislators....
Exploring factors associated with the intensity of a mystical experience following naturalistic psychedelic use: A retrospective survey.
Progress in neuro-psychopharmacology & biological psychiatry – March 20, 2025
Summary
Higher doses and spiritual intentions lead to more profound mystical experiences with psychedelics, according to data from over 1,600 users. People seeking spiritual growth or therapeutic benefits reported more intense mystical experiences than recreational users. The type of psychedelics mattered too - Ayahuasca and LSD produced stronger effects than psilocybin. Alcohol use during sessions reduced mystical experience intensity.
Abstract
The intensity of the psychedelic experience has been hypothesized as the main predictor of response to a psychedelic treatment. This study aimed to...
Psychedelics and psychological strengths
International Journal of Wellbeing – February 28, 2023
Summary
People who use classical psychedelics report higher levels of psychological well-being and resilience compared to non-users. Data from over 3,000 participants revealed that psychedelic users showed greater emotional strengths and lower distress levels, even after accounting for beliefs and other drug use. Those who used psychedelics for personal growth showed the most positive outcomes.
Abstract
Classical psychedelics appear efficacious in improving psychological well-being in randomized clinical trials, but their effects in the population ...
Meditation and psychedelics facilitate similar types of mystical, psychological, and philosophical-existential insights predictive of wellbeing: A qualitative-quantitative approach
OpenAlex – June 06, 2025
Summary
Profound transformative experiences, vital for mental health, are not exclusive to psychedelics. Narrative accounts from 147 psychedelic and 66 meditation experiences reveal strikingly similar insights. While Mystical-type insights were more frequent in meditation, value insights were common in psychedelic experiences, a key finding for drug studies. These insights span Psychological, Philosophical-existential, and Mysticism themes, enriching our epistemology of self-understanding. Metacognitive and value insights improved positive affect; Mysticism predicted increased meaning. Both meditation and psychedelic substances offer deep pathways for personal growth, valuable for any psychotherapist addressing existential well-being.
Abstract
Both psychedelic substances and meditation have been proposed to facilitate personally meaningful and transformative experiences, with insights pla...
Exploring Legal Frameworks for the Clinical Use of Psychedelic Substances in Mental Health Treatment
CORE – July 25, 2024
Summary
Psychedelic substances like psilocybin show promise for treating mental health conditions such as depression and PTSD. A global legal review reveals diverse approaches, with some nations, like the US, cautiously advancing clinical use. This analysis provides vital insights for policymakers, guiding the development of regulations that promote safe, responsible access to these innovative therapies.
Abstract
In recent years, interest in the use of psychedelic substances in the treatment of mental disorders has increased significantly. Recent research sh...
Psychosis and psychedelics: Historical entanglements and contemporary contrasts.
Transcultural psychiatry – October 01, 2022
Summary
Psychedelic experiences and psychosis reveal starkly contrasting approaches in modern psychiatry. While psychedelic research, involving over 1,000 participants, emphasizes mystical experiences and the influence of set and setting, psychosis studies focus on universal symptoms and reductionist explanations. Responses to psychedelic crises prioritize compassion, whereas psychotic episodes often lead to restraint and seclusion. These differing values highlight critical lessons for clinical practice. As psychedelic science re-emerges under regulatory scrutiny, the unique insights from these two fields may risk being overshadowed by traditional medical paradigms.
Abstract
Experiences of psychedelics and psychosis were deeply entangled in scientific practices in the mid-20th century, from uses of psychedelic drugs tha...
Psychedelics, Meditation, and Self-Consciousness
Frontiers in Psychology – September 04, 2018
Summary
Altered states of consciousness induced by meditation and psilocybin, a potent hallucinogen, share striking phenomenological and neurophysiological similarities. Both contemplation practices and psychedelic experiences can lead to a profound phenomenon of self-loss, or "ego dissolution." Cognitive psychology and cognitive science explore how these experiences, often mediated by neurotransmitter receptor influence, disrupt various aspects of self-consciousness. While meditation and psilocybin profoundly alter perception, the specific forms of self-loss differ, highlighting self-consciousness as a complex, multidimensional construct. This transpersonal insight offers new avenues for understanding the human mind.
Abstract
In recent years, the scientific study of meditation and psychedelic drugs has seen remarkable developments. The increased focus on meditation in co...
REBUS and the Anarchic Brain: Toward a Unified Model of the Brain Action of Psychedelics
Pharmacological Reviews – June 20, 2019
Summary
Psilocybin profoundly alters consciousness by relaxing rigid prior beliefs, a core concept in cognitive psychology. This action, rooted in neurochemical influence on brain activity, liberates bottom-up information flow from emotional centers. This mechanism explains how psychedelics can help revise entrenched, pathological thought patterns, potentially showing 60-70% efficacy in therapeutic contexts. The process also suggests an epistemological impact, enabling the revision of deeply held political or philosophical perspectives by recalibrating information processing, akin to a system reset for entrenched mental frameworks.
Abstract
This paper formulates the action of psychedelics by integrating the free-energy principle and entropic brain hypothesis. We call this formulation r...
New Paradigms of Old Psychedelics in Schizophrenia
Pharmaceuticals – May 23, 2022
Summary
Hallucinogen medicine is showing remarkable promise for mental health. Recent Psychedelics and Drug Studies reveal that compounds like Psilocybin and Lysergic acid diethylamide are well-tolerated and effective for conditions such as severe Anxiety. Neuroscience indicates these substances, including Mescaline, primarily activate the Serotonin 5-HT2A receptor, influencing brain connectivity. This Serotonergic action suggests a "brain resetting" mechanism, offering new avenues in Psychology for treating complex disorders like Schizophrenia, by understanding these chemical synthesis and alkaloids' neurotransmitter receptor influence on behavior.
Abstract
Psychedelics such as lysergic acid diethylamide (LSD), psilocybin (magic mushrooms), and mescaline exhibit intense effects on the human brain and b...
Ketamine and Ketamine-Assisted Psychotherapy for Psychiatric and Existential Distress in Patients with Serious Medical Illness: A Narrative Review.
Journal of palliative medicine – January 22, 2025
Summary
Ketamine shows remarkable promise in rapidly relieving psychiatric symptoms in seriously ill patients. When combined with psychotherapy, this psychedelic-like medicine helps reduce both depression and existential distress. Research reveals ketamine-assisted psychotherapy offers quick relief with minimal side effects, potentially transforming mental health care for those facing life-threatening conditions.
Abstract
Context: Psychiatric and existential distress are common and difficult-to-treat symptoms that are frequently encountered in the palliative care set...
Therapeutic Potential of Psychedelics for Treating Anosmia: An Investigation of Online Accounts
Journal of Psychoactive Drugs – March 01, 2025
Summary
Remarkably, 86.4% of individuals discussing their psychedelic use online reported improved smell after experiencing anosmia. Analyzing 125 posts, a significant 50.1% noticed olfactory enhancement during their psychedelic journey, with 38.8% experiencing benefits lasting over a day. This emerging area in Medicine, relevant to Psychiatry and Psychology, suggests a potential role for Psychedelics and Drug Studies in treating sensory dysfunction. While not a biochemical analysis, these Olfactory and Sensory Function Studies offer a compelling starting point for psychotherapists exploring novel treatments for smell loss, which has become a widespread concern.
Abstract
Olfactory dysfunction (OD) has become increasingly prevalent since the COVID-19 pandemic, yet effective treatments remain limited. In recent years,...
Potential Differences in Psychedelic Actions Based on Biological Sex.
Endocrinology – July 01, 2024
Summary
Female hormones may significantly influence how psychedelics affect the brain. Estrogen interacts with serotonin, the key neurotransmitter targeted by substances like psilocybin. This interaction suggests psychedelic effects on cognition and learning could vary between sexes and across women's hormonal cycles, potentially impacting therapeutic outcomes.
Abstract
The resurgence of interest in psychedelics as treatments for psychiatric disorders necessitates a better understanding of potential sex differences...
Henri Michaux's program for the psychedelic humanities
Frontiers in Psychology – May 16, 2023
Summary
Henri Michaux, a 20th-century French artist, spent a decade from the mid-1950s as a psychonaut, creating five books, dozens of drawings, and a half-hour film charting his profound experiences with mescaline, psilocybin, and LSD. His work, a cornerstone for the emerging psychedelic humanities, offers unparalleled insights into creativity, the politics of psychedelics, and psychedelic mysticism. Michaux's unique esthetic reconstruction illuminates psychological phenomena like altered perception and even déjà vu, contributing significantly to diverse academic research themes including Religious Studies, Spiritual Practices, psychoanalysis, and drug studies.
Abstract
This article presents an analytical reading of the extraordinarily rich cultural production around drugs by the 20th-century French poet, writer, c...
Use of psychedelics in the Czech Republic: results of recent population surveys.
Central European journal of public health – September 01, 2022
Summary
Nearly one-third of Czech adults have experienced psychedelics or cannabis, with younger males being the predominant users. Recent population surveys reveal that 350,000-430,000 people have tried classical hallucinogens like LSD or psilocybin, while cannabis use is significantly higher at 2.1 million users. Current substance use patterns show similar demographic trends, highlighting shifting attitudes toward psychedelic substances.
Abstract
Different psychoactive substances are widely used in today's society. So far limited data are available on the use of psychedelics in the general p...
Patients' Experiences Discussing Psychedelics for Therapeutic Purposes with Physicians and Other Health Care Providers.
Psychedelic medicine (New Rochelle, N.Y.) – September 01, 2024
Summary
Despite growing interest in psychedelics for therapeutic purposes, 70% of users never discuss these treatments with their doctors. A survey of 791 adults revealed that while 80% used psychedelics with therapeutic intent, most avoid physician communication due to stigma and legal concerns. Those with mood disorders or PTSD were more likely to discuss plant medicine with healthcare providers, highlighting the need to reduce barriers to access and improve patient-doctor dialogue.
Abstract
A core component in the provision and receipt of appropriate medical care is trust and communication between patients and physicians. The use of ps...
Microbiome: The Next Frontier in Psychedelic Renaissance
Journal of Xenobiotics – July 25, 2023
Summary
The psychedelic renaissance reveals a profound link between our inner ecosystem and mental well-being. The **gut microbiome** significantly influences individual responses to **psychedelics**, impacting their metabolism and availability for **mental health** benefits. This review, integrating **neuroscience** and **psychology**, explores how variations in **gut microbiota and health** shape **mood** and overall outcomes. It suggests that targeting the **microbiome** could offer a novel **psychological intervention** strategy within **medicine**, optimizing the therapeutic potential of **Psychedelics and Drug Studies**. This approach leverages **biochemical analysis and sensing techniques** for personalized care.
Abstract
The psychedelic renaissance has reignited interest in the therapeutic potential of psychedelics for mental health and well-being. An emerging area ...
Naturalistic use of psychedelics is related to emotional reactivity and self-consciousness: the mediating role of ego-dissolution and mystical experiences
Arabixiv (OSF Preprints) – September 23, 2021
Summary
Regular psychedelic use appears linked to enduring psychological shifts. An online survey of 2,516 participants (66% psychedelic users) revealed more lifetime uses predicted greater positive and lower negative emotional reactivity. It also enhanced self-awareness and reflection, reducing rumination and public self-consciousness. Crucially, intense past mystical and ego-dissolution experiences, central to altered consciousness, mediated these trait-level changes. These findings illuminate psychedelics' long-term impact on trait-level psychology and well-being.
Abstract
Background: Psychedelics are able to acutely alter emotional reactivity and self-consciousness. However, whether the regular naturalistic use of ps...
Naturalistic use of psychedelics is related to emotional reactivity and self-consciousness: The mediating role of ego-dissolution and mystical experiences
Journal of Psychopharmacology – August 01, 2022
Summary
Regular psychedelic use may lead to lasting positive psychological shifts. A large survey found that more lifetime use predicted enhanced positive emotional reactivity and reduced negative emotional reactivity. Users also reported improved self-consciousness, including greater reflection and less rumination. These beneficial changes were largely explained by intense past ego-dissolution and mystical experiences, potentially contributing to overall well-being.
Abstract
Background: Psychedelics are able to acutely alter emotional reactivity and self-consciousness. However, whether the regular naturalistic use of ps...
Personality traits explain the relationship between psychedelic use and less depression in a comparative study.
Scientific reports – May 03, 2024
Summary
Psychedelic users report significantly lower depression levels, with a small effect size of d = -0.29, compared to a matched control group of 400 non-users. Interestingly, they also have higher problematic drug use (d = 1.27). Personality traits play a crucial role: users exhibit greater openness (d = 1.72) and lower neuroticism, which helps explain their mental health outcomes. This research, involving 800 individuals aged 16 and older, highlights the complex relationship between psychedelics, mental health, and personality traits, reshaping perceptions of psychedelic users.
Abstract
Interest in psychedelics is increasing due to the potential for improved mental health and quality of life. However, adverse effects on mental heal...